Cancer spread to the bone, Secondary cancers
Results
Phase 2
This trial was to see if a drug called saracatinib could reduce the pain that cancer spread to the bones can cause.
This trial was open for people to join between 2014 and 2017, and the team published the results in 2019.
Recruitment start: 13 March 2014
Recruitment end: 19 June 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr David Andrew
AstraZeneca
Experimental Cancer Medicine Centre (ECMC)
Medical Research Council (MRC)
NIHR Clinical Research Network: Cancer
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield
Last reviewed: 24 March 2021
CRUK internal database number: 11770